Skip to main page content
Accesskeys
  1. Ariyoshi K. [A report of the state of health in Zimbabwe]. Nihon Koshu Eisei Zasshi. 1991 Aug;38(8):575-83. PubMed PMID: 1747548.
  2. Weber J, Ariyoshi K. Lack of correlation between acidified HIV p24 antigen and plasma viraemia. AIDS. 1992 Apr;6(4):428-9. PubMed PMID: 1616639.
  3. Ariyoshi K, Weber J, Walters S. Contribution of maternal viral load to HIV-1 transmission. Lancet. 1992 Aug 15;340(8816):435. doi: 10.1016/0140-6736(92)91524-c. PubMed PMID: 1353593.
  4. Ariyoshi K, Harwood E, Chiengsong-Popov R, Weber J. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?. Lancet. 1992 Nov 21;340(8830):1257-8. doi: 10.1016/0140-6736(92)92953-d. PubMed PMID: 1359323.
  5. Katseni VL, Gilroy CB, Ryait BK, Ariyoshi K, Bieniasz PD, Weber JN, Taylor-Robinson D. Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1. Lancet. 1993 Jan 30;341(8840):271-3. doi: 10.1016/0140-6736(93)92617-3. PubMed PMID: 8093918.
  6. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, Kroll JS, Froebel K, McMichael A. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 1993 Apr 3;341(8849):860-1. doi: 10.1016/0140-6736(93)93063-7. PubMed PMID: 8096564.
  7. Bieniasz PD, Ariyoshi K, Bourelly MA, Bloor S, Foxall RB, Harwood EC, Weber JN. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV-1-infected individuals. AIDS. 1993 Jun;7(6):803-6. doi: 10.1097/00002030-199306000-00007. PubMed PMID: 8103340.
  8. Ariyoshi K, Bloor S, Bieniasz PD, Bourrelly M, Foxall R, Weber JN. Development of a rapid quantitative assay for HIV-1 plasma infectious viraemia-culture-PCR (CPID). J Med Virol. 1994 May;43(1):28-32. PubMed PMID: 7916032.
  9. Berry N, Ariyoshi K, Jobe O, Ngum PT, Corrah T, Wilkins A, Whittle H, Tedder R. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses. 1994 Aug;10(8):1031-7. doi: 10.1089/aid.1994.10.1031. PubMed PMID: 7811534.
  10. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med. 1995 Jan;1(1):59-64. PubMed PMID: 7584954.
  11. Kitchen VS, Skinner C, Ariyoshi K, Lane EA, Duncan IB, Burckhardt J, Burger HU, Bragman K, Pinching AJ, Weber JN. Safety and activity of saquinavir in HIV infection. Lancet. 1995 Apr 15;345(8955):952-5. doi: 10.1016/s0140-6736(95)90699-1. PubMed PMID: 7715294.
  12. Ariyoshi K, Cham F, Berry N, Jaffar S, Sabally S, Corrah T, Whittle H. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS. 1995 Jun;9(6):555-9. doi: 10.1097/00002030-199506000-00004. PubMed PMID: 7662192.
  13. Ariyoshi K, Berry N, Wilkins A, Ricard D, Aaby P, Nauclér A, Ngom PT, Jobe O, Jaffar S, Dias F, Tedder RS, Whittle H. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J Infect Dis. 1996 Jan;173(1):245-8. doi: 10.1093/infdis/173.1.245. PubMed PMID: 8537668.
  14. Bobkov A, Cheingsong-Popov R, Salminen M, McCutchan F, Louwagie J, Ariyoshi K, Whittle H, Weber J. Complex mosaic structure of the partial envelope sequence from a Gambian HIV type 1 isolate. AIDS Res Hum Retroviruses. 1996 Jan 20;12(2):169-171. doi: 10.1089/aid.1996.12.169. PubMed PMID: 8834467.
  15. Ariyoshi K, Cheingsong-Popov R, Wilkins A, Corrah T, Weber J, Whittle H. HIV-1 subtype B in west Africa. Lancet. 1996 Feb 3;347(8997):328. doi: 10.1016/s0140-6736(96)90503-6. PubMed PMID: 8569384.
  16. Aaby P, Ariyoshi K, Buckner M, Jensen H, Berry N, Wilkins A, Richard D, Larsen O, Dias F, Melbye M, Whittle H. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. AIDS. 1996 Nov;10(13):1585-90. doi: 10.1097/00002030-199611000-00019. PubMed PMID: 8931796.
  17. Xiang Z, Ariyoshi K, Wilkins A, Dias F, Whittle H, Breuer J. HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau. AIDS Res Hum Retroviruses. 1997 Apr 10;13(6):501-5. doi: 10.1089/aid.1997.13.501. PubMed PMID: 9100992.
  18. Ariyoshi K, Schim van der Loeff M, Sabally S, Cham F, Corrah T, Whittle H. Does HIV-2 infection provide cross-protection against HIV-1 infection?. AIDS. 1997 Jul;11(8):1053-4. PubMed PMID: 9223741.
  19. N'Gom PT, Jaffar S, Ricard D, Wilkins A, Ariyoshi K, Morgan G, Da Silva AP, Whittle HC. Immune stimulation by syphilis and malaria in HIV-2-infected and uninfected villagers in West Africa. Br J Biomed Sci. 1997 Dec;54(4):251-5. PubMed PMID: 9624734.
  20. Rowland-Jones S, Dong T, Krausa P, Sutton J, Newell H, Ariyoshi K, Gotch F, Sabally S, Corrah T, Kimani J, MacDonald K, Plummer F, Ndinya-Achola J, Whittle H, McMichael A. The role of cytotoxic T-cells in HIV infection. Dev Biol Stand. 1998;92:209-14. PubMed PMID: 9554277.
  21. Bertoletti A, Cham F, McAdam S, Rostron T, Rowland-Jones S, Sabally S, Corrah T, Ariyoshi K, Whittle H. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J Virol. 1998 Mar;72(3):2439-48. PubMed PMID: 9499105; PubMed Central PMCID: PMC109544.
  22. Ariyoshi K, Schim van der Loeff M, Cook P, Whitby D, Corrah T, Jaffar S, Cham F, Sabally S, O'Donovan D, Weiss RA, Schulz TF, Whittle H. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol. 1998 Mar-Apr;1(3):193-9. PubMed PMID: 10195242.
  23. McKnight A, Dittmar MT, Moniz-Periera J, Ariyoshi K, Reeves JD, Hibbitts S, Whitby D, Aarons E, Proudfoot AE, Whittle H, Clapham PR. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J Virol. 1998 May;72(5):4065-71. PubMed PMID: 9557695; PubMed Central PMCID: PMC109635.
  24. Rowland-Jones S, Colbert RA, Dong T, McAdam S, Brown M, Ariyoshi K, Sabally S, Whittle H, McMichael A. Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705. AIDS. 1998 Jul 30;12(11):1391-3. doi: 10.1097/00002030-199811000-00023. PubMed PMID: 9708421.
  25. Whittle HC, Ariyoshi K, Rowland-Jones S. HIV-2 and T cell recognition. Curr Opin Immunol. 1998 Aug;10(4):382-7. Review. PubMed PMID: 9722912.
  26. Ishikawa K, Fransen K, Ariyoshi K, Nkengasong JN, Janssens W, Heyndrickx L, Whittle H, Diallo MO, Ghys PD, Coulibaly IM, Greenberg AE, Piedade J, Canas-Ferreira W, van der Groen G. Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS. 1998 Aug 20;12(12):1419-25. doi: 10.1097/00002030-199812000-00003. PubMed PMID: 9727562.
  27. Grassly NC, Xiang Z, Ariyoshi K, Aaby P, Jensen H, Schim van der Loeff M, Dias F, Whittle H, Breuer J. Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. J Virol. 1998 Oct;72(10):7895-9. PubMed PMID: 9733826; PubMed Central PMCID: PMC110115.
  28. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, Blanchard T, Ariyoshi K, Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, Plummer FA. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest. 1998 Nov 1;102(9):1758-65. doi: 10.1172/JCI4314. PubMed PMID: 9802890; PubMed Central PMCID: PMC509124.
  29. Berry N, Ariyoshi K, Jaffar S, Sabally S, Corrah T, Tedder R, Whittle H. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol. 1998 Nov-Dec;1(7):457-68. PubMed PMID: 10195267.
  30. Ariyoshi K, Cham F, Berry N, Harding E, Sabally S, N'Gom PT, Ishikawa K, Corrah T, Tedder R, Whittle H. Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody. AIDS. 1998 Dec 24;12(18):2504-5. PubMed PMID: 9875593.
  31. Rowland-Jones SL, Dong T, Dorrell L, Ogg G, Hansasuta P, Krausa P, Kimani J, Sabally S, Ariyoshi K, Oyugi J, MacDonald KS, Bwayo J, Whittle H, Plummer FA, McMichael AJ. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Lett. 1999 Mar;66(1-3):9-14. PubMed PMID: 10203028.
  32. Jobe O, Ariyoshi K, Marchant A, Sabally S, Corrah T, Berry N, Jaffar S, Whittle H. Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection. Clin Exp Immunol. 1999 Jun;116(3):474-8. doi: 10.1046/j.1365-2249.1999.00914.x. PubMed PMID: 10361237; PubMed Central PMCID: PMC1905295.
  33. Ariyoshi K, Schim van der Loeff M, Berry N, Jaffar S, Whittle H. Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia. AIDS. 1999 Jun 18;13(9):1145-6. doi: 10.1097/00002030-199906180-00023. PubMed PMID: 10397550.
  34. Jaffar S, Ariyoshi K, Frith P, Okouchi Y, Sabally S, Ajewole T, Bailey R, Lee PS, Corrah T, Johnson G, Faal H, Whittle H. Retinal manifestations of HIV-1 and HIV-2 infections among hospital patients in The Gambia, west Africa. Trop Med Int Health. 1999 Jul;4(7):487-92. PubMed PMID: 10470340.
  35. Cook PM, Whitby D, Calabro ML, Luppi M, Kakoola DN, Hjalgrim H, Ariyoshi K, Ensoli B, Davison AJ, Schulz TF. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. AIDS. 1999 Jul 9;13(10):1165-76. doi: 10.1097/00002030-199907090-00004. PubMed PMID: 10416519.
  36. Ota MO, O'Donovan D, Alabi AS, Milligan P, Yamuah LK, N'Gom PT, Harding E, Ariyoshi K, Wilkins A, Whittle HC. Maternal HIV-1 and HIV-2 infection and child survival in The Gambia. AIDS. 2000 Mar 10;14(4):435-9. doi: 10.1097/00002030-200003100-00018. PubMed PMID: 10770547.
  37. O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, Whittle H. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS. 2000 Mar 10;14(4):441-8. doi: 10.1097/00002030-200003100-00019. PubMed PMID: 10770548.
  38. Ariyoshi K, Jaffar S, Alabi AS, Berry N, Schim van der Loeff M, Sabally S, N'Gom PT, Corrah T, Tedder R, Whittle H. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS. 2000 Mar 10;14(4):339-44. doi: 10.1097/00002030-200003100-00006. PubMed PMID: 10770535.
  39. Ariyoshi K, Whittle H. HIV-1 viral load and scrub typhus. Lancet. 2000 Nov 18;356(9243):1766; author reply 1766-7. doi: 10.1016/S0140-6736(05)71954-1. PubMed PMID: 11095279.
  40. Berry N, Ariyoshi K, Balfe P, Tedder R, Whittle H. Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b. AIDS Res Hum Retroviruses. 2001 Feb 10;17(3):263-7. doi: 10.1089/088922201750063197. PubMed PMID: 11177410.
  41. Frater AJ, Beardall A, Ariyoshi K, Churchill D, Galpin S, Clarke JR, Weber JN, McClure MO. Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients. AIDS. 2001 Aug 17;15(12):1493-502. doi: 10.1097/00002030-200108170-00006. PubMed PMID: 11504981.
  42. Yagyu F, Ikeda Y, Ariyoshi K, Sugiura W, Wongkhomthong SA, Masuda M, Ushijima H. Differentiation of subtypes B and E of human immunodeficiency virus type 1 by polymerase chain reaction using novel env gene primers. J Virol Methods. 2002 Mar;101(1-2):11-20. PubMed PMID: 11849679.
  43. Frater AJ, Dunn DT, Beardall AJ, Ariyoshi K, Clarke JR, McClure MO, Weber JN. Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS. 2002 May 24;16(8):1139-46. doi: 10.1097/00002030-200205240-00007. PubMed PMID: 12004272.
  44. Ariyoshi K, Promadej N, Ruxrungtham K, Sutthent R. Toward improved evaluation of cytotoxic T-lymphocyte (CTL)-inducing HIV vaccines in Thailand. AIDS Res Hum Retroviruses. 2002 Jul 1;18(10):737-9. doi: 10.1089/088922202760072384. PubMed PMID: 12167283.
  45. Holmgren B, Andersson S, Harding E, Schim van der Loeff M, Vastrup P, Aaby P, Ariyoshi K, Whittle H. Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau. J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):342-50. PubMed PMID: 12131572.
  46. Schim van der Loeff MF, Jaffar S, Aveika AA, Sabally S, Corrah T, Harding E, Alabi A, Bayang A, Ariyoshi K, Whittle HC. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS. 2002 Sep 6;16(13):1775-83. doi: 10.1097/00002030-200209060-00010. PubMed PMID: 12218389.
  47. Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, N'Gom PT, Dias F, Wilkins A, Ricard D, Aaby P, Tedder R, Whittle H. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1167-73. doi: 10.1089/08892220260387904. PubMed PMID: 12487822.
  48. Myint L, Ariyoshi K, Yan H, Frater AJ, Auwanit W, Pathipvanith P, Yamada K, Matsuda M, Chiba T, Fujita K, McClure M, Weber JN, Sugiura W. Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2002 Dec;46(12):3861-8. doi: 10.1128/aac.46.12.3861-3868.2002. PubMed PMID: 12435689; PubMed Central PMCID: PMC132767.
  49. Pathipvanich P, Ariyoshi K, Rojanawiwat A, Wongchoosie S, Yingseree P, Yoshiike K, Warachit P, Sawanpanyalert P. Survival benefit from non-highly active antiretroviral therapy in a resource-constrained setting. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):157-60. PubMed PMID: 12571525.
  50. Ariyoshi K, Matsuda M, Miura H, Tateishi S, Yamada K, Sugiura W. Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):336-42. PubMed PMID: 12843744.